m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0236)
| Name |
RG7388
|
||||
|---|---|---|---|---|---|
| Formula |
C31H29Cl2F2N3O4
|
||||
| InChI |
1S/C31H29Cl2F2N3O4/c1-30(2,3)14-24-31(15-36,19-10-9-17(32)13-21(19)34)25(18-6-5-7-20(33)26(18)35)27(38-24)28(39)37-22-11-8-16(29(40)41)12-23(22)42-4/h5-13,24-25,27,38H,14H2,1-4H3,(H,37,39)(H,40,41)/t24-,25-,27+,31-/m0/s1
|
||||
| InChIKey |
TVTXCJFHQKSQQM-LJQIRTBHSA-N
|
||||
| TTD Drug ID | |||||
| DrugBank ID | |||||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Drug
| In total 1 item(s) under this drug | ||
| Crosstalk ID: M6ACROT00127 | ||
| m6A Regulator | Methyltransferase-like 3 (METTL3) | |
| m6A Target | Interferon-inducible protein 4 (ADAR1) | |
| Epigenetic Regulator | Interferon-inducible protein 4 (ADAR1) | |
| Regulated Target | E3 ubiquitin-protein ligase Mdm2 (Mdm2) | |
| Crosstalk relationship | m6A → A-to-I | |